YCBD Stock: cbdMD, Inc. Stock Price, Analysis & Insights
Get live ycbd stock price $2.27, comprehensive cbdMD, Inc. stock analysis, charts, news, and expert forecast. Real-time ycbd stock data and investment insights.
Loading chart...
Company Overview
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
Company Information
- CEO
- T. Ronan Kennedy
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 42
Contact Information
- Website
- https://www.cbdmd.com
- Address
- 8845 Red Oak Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 2.8)
✓ Higher growth potential with elevated volatility (Beta: 2.23)
Business Model & Strategy
cbdMD, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO T. Ronan Kennedy, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - Specialty & Generic model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
cbdMD, Inc. competes in the Drug Manufacturers - Specialty & Generic within the broader Healthcare. With 20.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange Arca, cbdMD, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating cbdMD, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for cbdMD, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for cbdMD, Inc.
- ⚠Investors should consider how cbdMD, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
20.25M
P/E Ratio
2.80
Beta
2.23
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 20.25M market capitalization
- Trading Volume: 148.99M shares traded today
- Price Range: 52-week range of $0.47 - $6.54
- Exchange: Listed on New York Stock Exchange Arca
Financial Metrics
Market Analysis for cbdMD, Inc.
cbdMD, Inc. (YCBD) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. With a current market capitalization of 20.25M, the company represents a significant player in its market. The stock is currently trading at $2.27 with a positivedaily change of 58.74%.
The company's 42 employee base and presence on the New York Stock Exchange Arcaexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 2.80, beta of 2.23, and 52-week price range from $0.47 to $6.54when evaluating investment opportunities.
Why Invest in cbdMD, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange Arca)
- • Experienced leadership under T. Ronan Kennedy
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.